These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34088339)

  • 1. RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.
    Sodi A; Banfi S; Testa F; Della Corte M; Passerini I; Pelo E; Rossi S; Simonelli F;
    Orphanet J Rare Dis; 2021 Jun; 16(1):257. PubMed ID: 34088339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voretigene Neparvovec for the Treatment of RPE65-associated Retinal Dystrophy: Consensus and Recommendations from the Korea RPE65-IRD Consensus Paper Committee.
    Han J; Joo K; Kim US; Woo SJ; Lee EK; Lee JY; Park TK; Kim SJ; Byeon SH
    Korean J Ophthalmol; 2023 Apr; 37(2):166-186. PubMed ID: 36950921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease.
    Johnson S; Buessing M; O'Connell T; Pitluck S; Ciulla TA
    JAMA Ophthalmol; 2019 Oct; 137(10):1115-1123. PubMed ID: 31318398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voretigene neparvovec-rzyl for treatment of
    Ciulla TA; Hussain RM; Berrocal AM; Nagiel A
    Expert Opin Biol Ther; 2020 Jun; 20(6):565-578. PubMed ID: 32149547
    [No Abstract]   [Full Text] [Related]  

  • 5. Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy.
    Kang C; Scott LJ
    Mol Diagn Ther; 2020 Aug; 24(4):487-495. PubMed ID: 32535767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Management of Patients with RPE65 Mutation-Associated Inherited Retinal Degenerations in Europe: Results of a Multinational Survey by the European Vision Institute Clinical Research Network.
    Lorenz B; Tavares J; van den Born LI; Marques JP; Scholl HPN;
    Ophthalmic Res; 2021; 64(5):740-753. PubMed ID: 33684911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting.
    Lorenz B; Künzel SH; Preising MN; Scholz JP; Chang P; Holz FG; Herrmann P
    Ophthalmology; 2024 Feb; 131(2):161-178. PubMed ID: 37704110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey.
    Mack HG; Chen FK; Grigg J; Jamieson R; De Roach J; O'Hare F; Britten-Jones AC; McGuinness M; Tindill N; Ayton L;
    BMJ Open; 2021 Jun; 11(6):e048361. PubMed ID: 34158306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inherited retinal dystrophy: first results of RPE65 gene replacement therapy in Russia].
    Kadyshev VV; Zolnikova IV; Khalanskaya OV; Stepanova AA; Kutsev SI
    Vestn Oftalmol; 2022; 138(4):48-57. PubMed ID: 36004591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Management of Patients with RPE65 Mutation Associated Inherited Retinal Degenerations in Europe: Results of a 2-Year Follow-Up Multinational Survey.
    Lorenz B; Tavares J; van den Born LI; Marques JP; Pilotto E; Stingl K; Charbel Issa P; Leroux D; Dollfus H; Scholl HPN
    Ophthalmic Res; 2023; 66(1):727-748. PubMed ID: 36878196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics and management of patients with inherited retinal diseases in Germany : Results of a nationwide survey of university and non-university eye departments and specialized practices].
    Künzel SH; Mahren E; Morr M; Holz FG; Lorenz B;
    Ophthalmologie; 2023 Nov; 120(11):1127-1137. PubMed ID: 37582888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited Retinal Diseases Due to
    Aoun M; Passerini I; Chiurazzi P; Karali M; De Rienzo I; Sartor G; Murro V; Filimonova N; Seri M; Banfi S
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
    Russell S; Bennett J; Wellman JA; Chung DC; Yu ZF; Tillman A; Wittes J; Pappas J; Elci O; McCague S; Cross D; Marshall KA; Walshire J; Kehoe TL; Reichert H; Davis M; Raffini L; George LA; Hudson FP; Dingfield L; Zhu X; Haller JA; Sohn EH; Mahajan VB; Pfeifer W; Weckmann M; Johnson C; Gewaily D; Drack A; Stone E; Wachtel K; Simonelli F; Leroy BP; Wright JF; High KA; Maguire AM
    Lancet; 2017 Aug; 390(10097):849-860. PubMed ID: 28712537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voretigene Neparvovec Gene Therapy in Clinical Practice: Treatment of the First Two Italian Pediatric Patients.
    Testa F; Melillo P; Della Corte M; Di Iorio V; Brunetti-Pierri R; Citro A; Ferrara M; Karali M; Annibale R; Banfi S; Rossi S; Simonelli F
    Transl Vis Sci Technol; 2021 Aug; 10(10):11. PubMed ID: 34554209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier frequency and incidence estimation of RPE65-associated inherited retinal diseases in East Asian population by population database-based analysis.
    Cho EH; Park JE; Lee T; Ha K; Ki CS
    Orphanet J Rare Dis; 2022 Nov; 17(1):409. PubMed ID: 36352427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic
    Kiraly P; Cottriall CL; Taylor LJ; Jolly JK; Cehajic-Kapetanovic J; Yusuf IH; Martinez-Fernandez de la Camara C; Shanks M; Downes SM; MacLaren RE; Fischer MD
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optometrist's guide to the top candidate inherited retinal diseases for gene therapy.
    O'Hare F; Edwards TL; Hu ML; Hickey DG; Zhang AC; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):431-443. PubMed ID: 33689629
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.